This article is based on a poster originally authored by Sanaz Koosha, Manpreet Singh, Eva Van Lombergen, Bieke Soen, Matthias De Decker, Leen Catrysse and Nithianandan Selliah. Precise ...
MUC1/HER2/neu peptide-based immunotherapeutic vaccines for breast adenocarcinomas. This is an ASCO Meeting Abstract from the 2011 ASCO Annual Meeting I. This abstract does not include a full text ...
T cells play essential roles in the adaptive immune response against pathogens and cancer cells. T cells specifically recognize peptide antigens loaded on the major histocompatibility complex (peptide ...
Effect of RNAi-based β-catenin inhibition on immunosuppressive Wnt-activated tumors in combination with IDOi/PD-1 immunotherapy. There was a systematic decrease of CD3e or CD3z expression at the RNA ...
The development of conventional T and B lymphocytes is fine and strictly tuned 1. The phenotypical differences between T and B cells are usually thought to be clear, which can be readily discerned ...
Treatment with anti-CD19 bispecific T-cell engager and CAR T therapies can lead to T-cell exhaustion and treatment failure. Novartis AG’s first-in-class anti-CD19, anti-CD3 and anti-CD2 IgG-like ...
(1) A chimeric antigen receptor (CAR) is a modular, synthetic receptor that endows T cells with different targeting abilities. Several emerging engineering approaches aim to improve the safety, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results